Asdren Zajmi

Asdren Zajmi

Management and Science University, Shah Alam, Selangor, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2012 in Phytomedicine
Verified
Journal Article
Closed access
SMSyam Mohan
Syam Mohan
SASiddig Ibrahim Abdelwahab
Siddig Ibrahim Abdelwahab
BKBehnam Kamalidehghan
Behnam Kamalidehghan
SSSuvitha Syam
Suvitha Syam
KMKoh Sue May
Koh Sue May
Asdren ZajmiAsdren Zajmi
Asdren Zajmi

22 April 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
Asdren ZajmiAsdren Zajmi
Asdren Zajmi
JTJeanette W P Teo
Jeanette W P Teo
Chew Chieng YeoChew Chieng Yeo
Chew Chieng Yeo
Elizabethkingia spp. is a ubiquitous pathogenic bacterium that has been identified as the causal agent for a variety of conditions such as meningitis, pneumonia, necrotizing fasciitis, endophthalmitis, and sepsis and is emerging as a global threat including in Southeast Asia. Elizabethkingia infections tend to be associated with high mortality rates (18.2–41%) and are mostly observed in neonates and immunocompromised patients. Difficulties in precisely identifying Elizabethkingia at the species level by traditional methods have hampered our understanding of this genus in human infections. In Southeast Asian countries, hospital outbreaks have usually been ascribed to E. meningoseptica, whereas in Singapore, E. anophelis was reported as the main Elizabethkingia spp. associated with hospital settings. Misidentification of Elizabethkingia spp. could, however, underestimate the number of cases attributed to the bacterium, as precise identification requires tools such as MALDI-TOF MS, and particularly whole-genome sequencing, which are not available in most hospital laboratories. Elizabethkingia spp. has an unusual antibiotic resistance pattern for a Gram-negative bacterium with a limited number of horizontal gene transfers, which suggests an intrinsic origin for its multidrug resistance. Efforts to prevent and further understand Elizabethkingia spp. infections and limit its spread must rise to this new challenge.

1 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Asdren ZajmiAsdren Zajmi
Asdren Zajmi
NHNajihah Mohd Hashim
Najihah Mohd Hashim
MNMohamed Ibrahim Noordin
Mohamed Ibrahim Noordin
SKShaden A M Khalifa
Shaden A M Khalifa
FRFaiqah Ramli
Faiqah Ramli
HEHesham R El-Seedi
Hesham R El-Seedi
Staphylococci are facultative anaerobes, perfectly spherical un-encapsulated cocci, with a diameter not exceeding 1 micrometer in diameter. Staphylococcus aureus are generally harmless and remain confined to the skin unless they burrow deep into the body, causing life-threatening infections in bones, joints, bloodstream, heart valves and lungs. Among the 20 medically important staphylococci species, Staphylococcus aureus is one of the emerging human pathogens. Streptomycin had its highest potency against Staphylococcus infections despite the likelihood of getting a resistant type of staphylococcus strains. Methicillin-resistant S. aureus (MRSA) is the persister type of Staphylococcus aureus and was evolved after decades of antibiotic misuse. Inadequate penetration of the antibiotic is one of the principal factors related to success/failure of the therapy. The active drug needs to reach the bacteria at concentrations necessary to kill or suppress the pathogen's growth. In turn the effectiveness of the treatment relied on the physical properties of Staphylococcus aureus. Thus understanding the cell integrity, shape and roughness is crucial to the overall influence of the therapeutic agent on S. aureus of different origins. Hence our experiments were designed to clarify ultrastructural changes of S. aureus treated with streptomycin (synthetic compound) in comparison to artonin E (natural compound). In addition to the standard in vitro microbial techniques, we used transmission electron microscopy to study the disrupted cell architecture under antibacterial regimen and we correlate this with scanning electron microscopy (SEM) to compare results of both techniques.

1 June 2017 in Asian Pacific Journal of Tropical Biomedicine
Verified
Journal Article
Open access
NANazeh M. Al-Abd
Nazeh M. Al-Abd
ZNZurainee Mohamed Nor
Zurainee Mohamed Nor
MMMarzida Mansor
Marzida Mansor
Asdren ZajmiAsdren Zajmi
Asdren Zajmi
MHM. Shahnaz Hasan
M. Shahnaz Hasan
MKMustafa Kassim
Mustafa Kassim
Objective: To investigate the antioxidant, antibacterial, and chemical ingredients of Ardisia elliptica (A. elliptica) methanolic extracts. Methods: The plant was extracted using methanol. Antibacterial and antioxidant activities were evaluated. Results: The results showed that both fruit and leaf extract of A. elliptica have significant antibacterial activities against Gram-positive and Gram-negative bacteria. Fruit extracts showed higher content of phenolic (71 ± 0.03 GAE/mg extract dry weight), in comparison to the leaf extracts (37 ± 0.05 GAE/mg extract dry weight). Flavonoid content, and Fe2+ chelating activity of fruit extracts were higher than leaf extract. The percentage radical inhibition of fruit extract is found to be higher (70%) than that of leaf extract (60%). LCMS results indicated that the major compounds in the fruit extract were Gingerol, Aspidin, Kampherol, and Stercuresin, while the leaf extract contained Gingerol, Aspidin, Triangularin, and Salicyl acyl glucuronide. Furthermore, the results of GCMS indicated that fruit extract contained these major compounds: Vitamin E Tocopherol, 5-hepylresornicol, 2-Nonylmalonic acid, 5-pentadecylresornicol, and Stigmasta-7-22-dien-3-ol. However, leaf extract of A. elliptica contained these major compounds: Alpha Amyrenol, 4,4, 6, 6a, 6b, 8, 8a, 9,10, 11,12,12a, 14, 14a, 14b octadehydro-2H-picen-3-one, and Lonasterol, 4-t-Butyl-2-[4-nitrophenyl] phenol. Conclusions: The results provide evidence that fruit and leaf of A. elliptica extracts might indeed be used as a potential source of effective natural antimicrobial and antioxidant agents in pharmaceutical and food industries

29 July 2013 in Molecules
Verified
Journal Article
Open access
PDF file
HHHadi Hamid
Hadi Hamid
NHNajihah Mohd. Hashim
Najihah Mohd. Hashim
Asdren ZajmiAsdren Zajmi
Asdren Zajmi
NNNoraziah Nordin
Noraziah Nordin
SASiddig Ibrahim Abdelwahab
Siddig Ibrahim Abdelwahab
HAHapipah Mohd Ali
Hapipah Mohd Ali
The oxoaporphine alkaloid lysicamine (1), and three proaporphine alkaloids, litsericinone (2), 8,9,11,12-tetrahydromecambrine (3) and hexahydromecambrine A (4) were isolated from the leaves of Phoebe grandis (Nees) Merr. (Lauraceae). Compounds 2 and 3 were first time isolated as new naturally occurring compounds from plants. The NMR data for the compounds 2–4 have never been reported so far. Compounds 1 and 2 showed significant cytotoxic activity against a MCF7 (human estrogen receptor (ER+) positive breast cancer) cell line with IC50 values of 26 and 60 µg/mL, respectively. Furthermore, in vitro cytotoxic activity against HepG2 (human liver cancer) cell line was evaluated for compounds 1–4 with IC50 values of 27, 14, 81 and 20 µg/mL, respectively. Lysicamine (1) displayed strong antibacterial activity against Bacillus subtilis (B145), Staphylococcus aureus (S1434) and Staphylococus epidermidis (a clinically isolated strain) with inhibition zones of 15.50 ± 0.57, 13.33 ± 0.57 and 12.00 ± 0.00 mm, respectively. However, none of the tested pathogenic bacteria were susceptible towards compounds 2 and 3.

28 December 2017 in Malaysian Journal of Science
Verified
Journal Article
Open access
PDF file
NANazeh Ali
Nazeh Ali
MKMustafa Kassim
Mustafa Kassim
Asdren ZajmiAsdren Zajmi
Asdren Zajmi
Galangin is an active flavonoid compound found in various plants, and is one of the primary constituents of honey and propolis. It has antioxidant, anti-inflammatory, antimicrobial and hepatoprotective properties. This study is intended to evaluate the effects of galangin on cytokines and nitric oxide (NO) secretion from microglia BV2 after being induced with lipopolysaccharide. Microglia BV2 was incubated with Galangin (with and without LPS) and dexamethasone for 24h. NO production in the cultured supernatant was measured with the Griess reaction. IL-6, IL-10, and TNF-α levels were measured using immunoassay. Results indicated that galangin did not exert cytotoxicity effect on the cell viability of BV2 macroglia at concentrations less than 40 µg/mL. It was also observed that galangin had significantly suppressed the production of cytokines, such as IL-6, IL-10 and TNF-α, as well as NO in LPS-induced BV2 cells. The antioxidant and anti-inflammatory properties of galangin are associated with its ability to inhibit NO and cytokines. Our results further showed the potential impact of galangin, thus suggesting that further development is feasible in order to leverage on its promising antioxidant and anti-inflammatory effects in treating neuroinflammatory diseases. Key words: Galangin; Lipopolysaccharide (LPS); Nitric oxide (NO); Cytokines; Microglia BV2.